How would symbicort (budesonide and formoterol) affect cardiomyopathy?

See below: Symbicort (budesonide and formoterol) is a treatment of lung disease and some cardiomyopathies are due to lung problems, especially sleep apnea. Symbicort (budesonide and formoterol) may alleviate pulmonary symptoms and consequently alleviate the lung burden to the heart (in cardiomyopathies due to lung problems). But it usually requires also treatment such as weight loss and CPAP - positive pressure.

No effect: Symbicort, (budesonide and formoterol) if taken in prescribed doses, will not have any significant effect on the course of cardiomyopathy. That said, some people with cmp may be particularly sensitive to the arrhythmogenic effects (the tendency to cause irregularity of the heart rhythm) and must be cautious and/or monitored.